Show simple item record

FieldValueLanguage
dc.contributor.authorBrown, Christopher
dc.date.accessioned2020-11-20
dc.date.available2020-11-20
dc.date.issued2020en_AU
dc.identifier.urihttps://hdl.handle.net/2123/23917
dc.description.abstractThe hydroxamic acid (HXA) functional group is a class of organic acid that forms stable complexes with a range of metal ions. The HXA group has been useful in therapeutic areas, such as iron chelation therapy and radiometal-immunological PET imaging. Multimeric HXA-containing compounds can adopt either macrocyclic or linear structural architectures, as comprised from endo-HXA monomeric subunits. Obtaining these endo-HXA monomers synthetically is difficult, due to low yields and inefficient reaction times. This creates issues when synthesising macrocyclic or linear products from these subunits and inhibits the ability to study these compounds in a therapeutic setting. One aim of this thesis was to revise the synthesis of the endo-HXA monomer. Subsequent to this, the endo-HXA monomers were deployed to create macrocyclic compounds using synthetic techniques, such as metal-templated synthesis (MTS) and metal-assisted ring closure (MARC). Linear constructs were produced using amide-coupling chemistry to graft an endo-HXA monomer onto the native HXA-containing desferrioxamine B (DFOB). This thesis improved the yield and efficiency of accessing endo-HXA monomers using a tailored protecting group strategy. Furthermore, endo-HXA monomer analogues were produced, which were used to create structural variation in macrocyclic and linear compounds. The endo-HXA monomers were used in an MTS approach to generate dimeric HXA macrocycles. This technique yielded analytical quantities of material. Access to these constructs was improved upon by using the MARC synthetic technique, which required the formation of one rather than two amide bonds. Linear constructs were created by amide coupling a variety of endo-HXA monomers to DFOB. These ligands could be useful in 89Zr immunological PET imaging. This thesis describes the improved synthesis of endo-HXA monomers that allowed the creation of unique macrocyclic and linear architectures that could be useful in a therapeutic setting.en_AU
dc.language.isoenen_AU
dc.publisherUniversity of Sydneyen_AU
dc.subjecthydroxamicen_AU
dc.subjectaciden_AU
dc.subjectmacrocyclesen_AU
dc.subjectDesferrioxamine Ben_AU
dc.subjecthydroxamic aciden_AU
dc.titleImproved Access to New Hydroxamic Acid Macrocycles and Linear Analoguesen_AU
dc.typeThesis
dc.type.thesisDoctor of Philosophyen_AU
dc.rights.otherThe author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.en_AU
usyd.facultySeS faculties schools::Faculty of Medicine and Health::School of Medical Sciencesen_AU
usyd.departmentDiscipline of Pharmacologyen_AU
usyd.degreeDoctor of Philosophy Ph.D.en_AU
usyd.awardinginstThe University of Sydneyen_AU
usyd.advisorCODD, RACHEL


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.